Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Scilex Holding (SCLX) Receivables (2021 - 2025)

Scilex Holding has reported Receivables over the past 5 years, most recently at $15.2 million for Q4 2025.

  • On a quarterly basis, Receivables fell 42.35% to $15.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.2 million, a 42.35% decrease, with the full-year FY2025 number at $15.2 million, up 376.38% from a year prior.
  • Receivables reached $15.2 million in Q4 2025 per SCLX's latest filing, up from $11.9 million in the prior quarter.
  • The five-year high for Receivables was $34.6 million in Q4 2023, with the low at $3.2 million in Q3 2023.
  • The 5-year median for Receivables is $16.0 million (2025), against an average of $18.1 million.
  • The largest YoY upside for Receivables was 886.88% in 2024 against a maximum downside of 88.39% in 2024.
  • Tracing SCLX's Receivables over 5 years: stood at $14.3 million in 2021, then soared by 48.84% to $21.2 million in 2022, then skyrocketed by 62.92% to $34.6 million in 2023, then decreased by 23.57% to $26.4 million in 2024, then plummeted by 42.35% to $15.2 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $15.2 million, $11.9 million, and $16.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.